Last reviewed · How we verify
NCT04860934
Dual Task Training On Children With Ataxia After Medulloblastoma Resection
NA trial testing Dual Task Training Program Group in Medulloblastoma, Childhood in 30 participants. Completed in 30 November 2021.
15 November 2021
Quick facts
| Lead sponsor | Children's Cancer Hospital Egypt 57357 |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 15 March 2021 |
| Primary completion | 15 November 2021 |
| Estimated completion | 30 November 2021 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Dual Task Training Program Group
- Control Group — full drug profile →
Conditions studied
- Medulloblastoma, Childhood — all drugs for Medulloblastoma, Childhood →
- Childhood Cancer — all drugs for Childhood Cancer →
Sponsor
Children's Cancer Hospital Egypt 57357
Who can join
Adults 5 to 10, any sex, with Medulloblastoma, Childhood or Childhood Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Medulloblastoma is a rapidly-growing tumor of the cerebellum, this area controls balance, posture and sophisticated motor functions like finer hand movements, speech, and swallowing. With the goal of, complete resection, major complications during tumor removal are usually caused by damage to the brain stem and injury to the lower cranial nerves.It has been reported that those children present Ataxia after resection. So the purpose of this study is to investigate the effectiveness of using a selected dual-task- training program to improve postural stability in those Children.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04860934
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Medulloblastoma, Childhood
Currently open trials in the same condition.
- NCT06942039 — Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · EARLY_PHASE1 · recruiting
- NCT06959979 — Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma · EARLY_PHASE1 · recruiting
- NCT06193759 — Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) · Phase 1 · recruiting
- NCT05230758 — Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour · Phase 3 · recruiting
- NCT05057702 — Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma · NA · recruiting
Other Children's Cancer Hospital Egypt 57357 trials
Trials by the same sponsor.
- NCT05452668 — Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia Patients · NA · unknown
- NCT06267417 — Laser Therapy Effect as Preventive Measure for Oral Mucositis in Children With Hematological Malignancies · NA · completed
- NCT05493228 — Dexmedetomidine Infusion on Intraoperative Propofol,Fentanyl Requirements in Spine Surgery for Pediatric Cancer Patients · Phase 3 · unknown
- NCT05024253 — Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements. · Phase 3 · completed
- NCT04528316 — Physical Activity on Postural Stability and Coordination in Children With Posterior Fossa Tumor · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04860934 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Cancer Hospital Egypt 57357
- Last refreshed: 8 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04860934.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing